Fenfluramine in CDKL5 Deficiency Disorder (CDD)
NCT03861871
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
7
Enrollment
OTHER
Sponsor class
Conditions
CDD
Interventions
DRUG:
Fenfluramine Hydrochloride
Sponsor
NYU Langone Health